In Reply

Tehran University of Medical Sciences

Science Communicator Platform

Share By

In Reply Publisher Pubmed

Ghassemi F¹ ; Shields CL² ; Khodabande A¹

Source: JAMA Ophthalmology Published:2015

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Addition of Intravitreal Carboplatin With Melphalan for Management of Vitreous Seeding in Retinoblastoma, Graefe's Archive for Clinical and Experimental Ophthalmology (2023)

2. Risk Definition and Management Strategies in Retinoblastoma: Current Perspectives, Clinical Ophthalmology (2015)

3. Ocular Safety of Repeated Intravitreal Injections of Carboplatin and Digoxin: A Preclinical Study on the Healthy Rabbits, Pharmacology Research and Perspectives (2021)

Experts (# of related papers)

View all Related Experts

Fariba Ghassemi (7)

Alireza Khodabandeh (3)

Other Related Docs

4. The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model, Journal of Ophthalmic and Vision Research (2023)

5. Five-Year Experience in Treatment of Retinoblastoma With Intra-Arterial Chemotherapy: A Single-Center Analysis, Journal of Current Ophthalmology (2021)

6. Efficacy of Topotecan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma, Experimental Eye Research (2021)

7. Retinal Optical Coherence Tomography Angiography Findings Following Retinoblastoma Treatment by Chemotherapy, Journal of Current Ophthalmology (2022)

8. Preparation and in Vivo Evaluation of Nanoliposomes Containing Melphalan After Intravitreal Injection in Albino Rabbits, Journal of Pharmaceutical Investigation (2016)

9. Co-Delivery of Mir-181A and Melphalan by Lipid Nanoparticles for Treatment of Seeded Retinoblastoma, Journal of Controlled Release (2019)

Style	Citing Format
MLA	Ghassemi F, Shields CL, Khodabande A. "In Reply." JAMA Ophthalmology, vol. 133, no. 2, 2015, pp. 232-233.
APA	Ghassemi F, Shields CL, Khodabande A (2015). In Reply. JAMA Ophthalmology, 133(2), 232-233.
Chicago	Ghassemi F, Shields CL, Khodabande A. "In Reply." JAMA Ophthalmology 133, no. 2 (2015): 232-233.
Harvard	Ghassemi F, Shields CL, Khodabande A (2015) 'In Reply', JAMA Ophthalmology, 133(2), pp. 232-233.
Vancouver	Ghassemi F, Shields CL, Khodabande A. In Reply. JAMA Ophthalmology. 2015;133(2):232-233.
BibTex	@article{ author = {Ghassemi F and Shields CL and Khodabande A}, title = {In Reply}, journal = {JAMA Ophthalmology}, volume = {133}, number = {2}, pages = {232-233}, year = {2015} }
RIS	TY - JOUR AU - Ghassemi F AU - Shields CL AU - Khodabande A TI - In Reply JO - JAMA Ophthalmology VL - 133 IS - 2 SP - 232 EP - 233 PY - 2015 ER -